Valor Intrínseco del S&P y Nasdaq Contáctenos

Amylyx Pharmaceuticals, Inc. AMLX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.00
+30%

Ha habido 50 transacciones internas recientes registradas para Amylyx Pharmaceuticals, Inc. (AMLX), incluyendo 17 compras y 31 ventas. El total de compras internas fue valorado en $19.97M y el total de ventas internas en $6.08M.

Internos destacados con actividad reciente incluyen Frates James M, Bedrosian Camille L, Klee Justin B.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — AMLX

Fecha Nombre Cargo Tipo de Transacción Acciones Precio Promedio Valor Acciones en Propiedad
2026-03-05 Frates James M Chief Financial Officer Concesión de RSU 143,985 $14.10 $2.03M 143,985
2026-03-05 Bedrosian Camille L Chief Medical Officer Concesión de RSU 143,985 $14.10 $2.03M 143,985
2026-03-05 Klee Justin B. Co-chief Executive Officer Concesión de RSU 373,295 $14.10 $5.26M 373,295
2026-03-05 Cohen Joshua B Co-chief Executive Officer Concesión de RSU 373,295 $14.10 $5.26M 373,295
2026-03-05 Mazzariello Gina Chief Legal Officer Concesión de RSU 111,990 $14.10 $1.58M 111,990
2026-03-02 Frates James M Chief Financial Officer Venta Informativa 7,909 $14.52 $114.85K 165,638
2026-03-02 Bedrosian Camille L Chief Medical Officer Venta Informativa 6,461 $14.58 $94.21K 169,295
2026-03-02 Klee Justin B. Co-chief Executive Officer Venta Informativa 29,282 $14.47 $423.76K 3,334,616
2026-03-02 Cohen Joshua B Co-chief Executive Officer Venta Informativa 29,282 $14.48 $424.12K 3,334,683
2026-03-02 Mazzariello Gina Chief Legal Officer Venta Informativa 6,844 $14.52 $99.38K 134,430
2026-02-23 Mazzariello Gina Chief Legal Officer Venta Informativa 3,419 $14.14 $48.35K 141,274
2026-02-02 Frates James M Chief Financial Officer Venta Informativa 3,557 $14.65 $52.1K 173,547
2026-02-02 Klee Justin B. Co-chief Executive Officer Venta Informativa 15,500 $14.69 $227.62K 3,363,898
2026-02-02 Cohen Joshua B Co-chief Executive Officer Venta Informativa 15,500 $14.68 $227.59K 3,363,965
2026-02-02 Mazzariello Gina Chief Legal Officer Venta Informativa 3,448 $14.65 $50.52K 144,693
2026-01-16 Klee Justin B. Co-chief Executive Officer Ejercicio de Opciones (Venta) 2,847 $7.57 $21.55K -
2026-01-16 Cohen Joshua B Co-chief Executive Officer Ejercicio de Opciones (Venta) 2,818 $7.57 $21.33K -
2026-01-15 Klee Justin B. Co-chief Executive Officer Ejercicio de Opciones (Venta) 197,153 $7.57 $1.49M 2,847
2026-01-15 Cohen Joshua B Co-chief Executive Officer Ejercicio de Opciones (Venta) 197,182 $7.57 $1.49M 2,818
2026-01-12 Milne George M Jr Director Donación (Otorgada) 17,780 - - 812,881
2026-01-06 Frates James M Chief Financial Officer Venta Informativa 3,326 $11.11 $36.95K 177,104
2026-01-06 Klee Justin B. Co-chief Executive Officer Venta Informativa 7,715 $11.09 $85.59K 3,317,586
2026-01-06 Cohen Joshua B Co-chief Executive Officer Venta Informativa 7,715 $11.09 $85.6K 3,317,632
2025-12-23 Firestone Karen Director Compra Informativa 8,100 $12.45 $100.85K 63,100
2025-12-01 Bedrosian Camille L Chief Medical Officer Venta Informativa 6,580 $14.35 $94.42K 175,756
2025-09-30 Frates James M Chief Financial Officer Venta Informativa 10,558 $14.65 $154.65K 280,430
2025-09-30 Bedrosian Camille L Chief Medical Officer Venta Informativa 12,039 $14.58 $175.52K 182,336
2025-09-30 Klee Justin B. Co-chief Executive Officer Venta Informativa 200 $15.01 $3K 3,325,301
2025-09-30 Cohen Joshua B Co-chief Executive Officer Venta Informativa 200 $15.00 $3K 3,325,347
2025-09-30 Mazzariello Gina Chief Legal Officer Venta Informativa 8,828 $14.58 $128.67K 148,141
2025-08-13 Mazzariello Gina Chief Legal Officer Venta Informativa 15,000 $8.34 $125.05K 156,969
2025-08-12 Mazzariello Gina Chief Legal Officer Venta Informativa 15,000 $8.07 $121.1K 171,969
2025-06-05 Milne George M Jr Director Concesión de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Quimi Daphne Director Concesión de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Fonteyne Paul R. Director Concesión de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Firestone Karen Director Concesión de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Zeiher Bernhardt G Director Concesión de RSU 25,000 $5.05 $126.25K 25,000
2025-05-22 Mazzariello Gina Chief Legal Officer Donación (Otorgada) 1,000 - - 186,969
2025-03-31 Frates James M Chief Financial Officer Venta Informativa 10,896 $3.47 $37.81K 290,988
2025-03-31 Bedrosian Camille L Chief Medical Officer Venta Informativa 12,425 $3.47 $43.08K 194,375
2025-03-31 Klee Justin B. Co-chief Executive Officer Venta Informativa 21,490 $3.46 $74.45K 3,355,276
2025-03-31 Cohen Joshua B Co-chief Executive Officer Venta Informativa 21,490 $3.47 $74.48K 3,355,280
2025-03-31 Mazzariello Gina Chief Legal Officer Venta Informativa 9,192 $3.48 $31.95K 187,969
2025-03-20 Zeiher Bernhardt G Director Compra Informativa 10,000 $3.70 $37.01K 10,000
2025-03-06 Frates James M Chief Financial Officer Concesión de RSU 102,630 $3.61 $370.49K 102,630
2025-03-06 Bedrosian Camille L Chief Medical Officer Concesión de RSU 102,630 $3.61 $370.49K 102,630
2025-03-06 Klee Justin B. Co-chief Executive Officer Concesión de RSU 270,177 $3.61 $975.34K 270,177
2025-03-06 Cohen Joshua B Co-chief Executive Officer Concesión de RSU 270,177 $3.61 $975.34K 270,177
2025-03-06 Mazzariello Gina Chief Legal Officer Concesión de RSU 95,777 $3.61 $345.75K 95,777
2025-03-03 Klee Justin B. Co-chief Executive Officer Venta Informativa 4,595 $3.15 $14.48K 3,196,648
Informativa — transacción en mercado abierto (más significativa) No informativa (compra) — premio, ejercicio de opción, conversión No informativa (venta) — retención fiscal, venta de adjudicación Neutral — regalo, fideicomiso, vencimiento
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje